Cargando…

Recurrence of primary biliary cholangitis after liver transplantation: A Japanese perspective

Detalles Bibliográficos
Autores principales:	Montano‐Loza, Aldo J., Mason, Andrew L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2017
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5721417/ https://www.ncbi.nlm.nih.gov/pubmed/29404467 http://dx.doi.org/10.1002/hep4.1058

Ejemplares similares

Vitamin D Is Associated with Clinical Outcomes in Patients with Primary Biliary Cholangitis
por: Ebadi, Maryam, et al.
Publicado: (2022)

Combination antiretroviral therapy improves recurrent primary biliary cholangitis following liver transplantation
por: Lytvyak, Ellina, et al.
Publicado: (2021)

Risk factors for recurrence of primary biliary cholangitis after liver transplantation in female patients: A Japanese multicenter retrospective study
por: Kogiso, Tomomi, et al.
Publicado: (2017)

A novel learning algorithm to predict individual survival after liver transplantation for primary sclerosing cholangitis
por: Andres, Axel, et al.
Publicado: (2018)

Predicting Risk in Primary Biliary Cholangitis
por: Cho, Eun Ju
Publicado: (2023)

Is there a Role for Cyclophilin Inhibitors in the Management of Primary Biliary Cirrhosis?
por: Wasilenko, Shawn T., et al.
Publicado: (2013)

Prognostic Significance of Severe Vitamin D Deficiency in Patients with Primary Sclerosing Cholangitis
por: Ebadi, Maryam, et al.
Publicado: (2023)

The More, the Better? Predicting Prognosis in Primary Biliary Cholangitis
por: Kim, Bo Hyun
Publicado: (2018)

Linking Human Betaretrovirus with Autoimmunity and Liver Disease in Patients with Primary Biliary Cholangitis
por: Syed, Hussain, et al.
Publicado: (2022)

Biomarkers for primary biliary cholangitis: current perspectives
por: Kouroumalis, Elias, et al.
Publicado: (2018)

Autoimmune biliary diseases: primary biliary cholangitis and primary sclerosing cholangitis
por: Sarcognato, Samantha, et al.
Publicado: (2021)

Recurrence of primary sclerosing cholangitis after liver transplantation – analysing the European Liver Transplant Registry and beyond
por: Visseren, Thijmen, et al.
Publicado: (2021)

Endothelin Signaling Mediates Biliary-Endothelial Crosstalk in Primary Sclerosing Cholangitis
por: Yin, Chunyue
Publicado: (2023)

Number needed to treat with ursodeoxycholic acid therapy to prevent liver transplantation or death in primary biliary cholangitis
por: Harms, Maren H, et al.
Publicado: (2020)

Trends in liver transplantation for primary biliary cholangitis in Europe over the past three decades
por: Harms, Maren H., et al.
Publicado: (2018)

Osteoporosis in primary biliary cholangitis
por: Danford, Christopher J, et al.
Publicado: (2018)

Baricitinib and primary biliary cholangitis
por: Gordon, Stuart C., et al.
Publicado: (2021)

Management of Primary Biliary Cholangitis: Current Treatment and Future Perspectives
por: Barba Bernal, Romelia, et al.
Publicado: (2023)

Symptoms and health-related quality of life in Japanese patients with primary biliary cholangitis
por: Yagi, Minami, et al.
Publicado: (2018)

Genome-wide haplotype association analysis of primary biliary cholangitis risk in Japanese
por: Im, Cindy, et al.
Publicado: (2018)

Prognostic utility of albumin-bilirubin grade in Japanese patients with primary biliary cholangitis
por: Yamashita, Yuki, et al.
Publicado: (2022)

The liver steatosis severity and lipid characteristics in primary biliary cholangitis
por: Zhang, Yuan, et al.
Publicado: (2021)

Overlap Syndrome between Primary Biliary Cholangitis and Primary Sclerosing Cholangitis
por: Sundaram, Sridhar, et al.
Publicado: (2018)

Evaluation of the United Kingdom‐primary biliary cholangitis and global primary biliary cholangitis group prognostic models for primary biliary cholangitis patients treated with ursodeoxycholic acid in the U.S. population
por: Alomari, Mohammad, et al.
Publicado: (2019)

Transplantation for Primary Sclerosing Cholangitis: Outcomes and Recurrence
por: Saner, Fuat H., et al.
Publicado: (2023)

Successful Treatment of Recurrent Primary Sclerosing Cholangitis after Orthotopic Liver Transplantation with Oral Vancomycin
por: Davies, Yinka K., et al.
Publicado: (2013)

Extrahepatic Manifestations of Primary Biliary Cholangitis
por: Chalifoux, Sara L, et al.
Publicado: (2017)

Obeticholic acid for primary biliary cholangitis
Publicado: (2020)

Current understanding of primary biliary cholangitis
por: Tanaka, Atsushi
Publicado: (2021)

Primary biliary cholangitis: pathogenic mechanisms
por: Prieto, Jesús, et al.
Publicado: (2021)

The Role of Epigenetics in Primary Biliary Cholangitis
por: Gerussi, Alessio, et al.
Publicado: (2022)

Obeticholic Acid for Primary Biliary Cholangitis
por: Floreani, Annarosa, et al.
Publicado: (2022)

Risk Stratification in Primary Biliary Cholangitis
por: Martini, Francesco, et al.
Publicado: (2023)

Understanding fatigue in primary biliary cholangitis: From pathophysiology to treatment perspectives
por: Lynch, Erica Nicola, et al.
Publicado: (2022)

Follicular T Helper Cell Signatures in Primary Biliary Cholangitis and Primary Sclerosing Cholangitis
por: Adam, Leonie, et al.
Publicado: (2018)

Primary Biliary Cholangitis and Primary Sclerosing Cholangitis: Current Knowledge of Pathogenesis and Therapeutics
por: Park, Ji-Won, et al.
Publicado: (2022)

Lymphocyte recruitment and homing to the liver in primary biliary cirrhosis and primary sclerosing cholangitis
por: Borchers, Andrea T., et al.
Publicado: (2009)

Efficacy of oral vancomycin in recurrent primary sclerosing cholangitis following liver transplantation
por: Hey, Penelope, et al.
Publicado: (2017)

The impact of primary biliary cholangitis on non-alcoholic fatty liver disease
por: Iluz-Freundlich, Daniel, et al.
Publicado: (2020)

Antimitochondrial antibody associated with liver cirrhosis in patients with primary biliary cholangitis
por: Jin, Yujiao, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_cub2d69m9m6a3befgngq3bccc1